Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

* This is a professional Version *

Allergic Rhinitis

by Peter J. Delves, PhD

Allergic rhinitis is seasonal or perennial itching, sneezing, rhinorrhea, nasal congestion, and sometimes conjunctivitis, caused by exposure to pollens or other allergens. Diagnosis is by history and occasionally skin testing. First-line treatment is with a nasal corticosteroid (with or without an oral or a nasal antihistamine) or with an oral antihistamine plus an oral decongestant.

Allergic rhinitis may occur seasonally or throughout the year (as a form of perennial rhinitis). Seasonal rhinitis is usually allergic. At least 25% of perennial rhinitis is nonallergic.

Seasonal allergic rhinitis (hay fever) is most often caused by plant allergens, which vary by season. Common plant allergens include

  • Spring: Tree pollens (eg, oak, elm, maple, alder, birch, juniper, olive)

  • Summer: Grass pollens (eg, Bermuda, timothy, sweet vernal, orchard, Johnson) and weed pollens (eg, Russian thistle, English plantain)

  • Fall: Other weed pollens (eg, ragweed)

Causes also differ by region, and seasonal allergic rhinitis is occasionally caused by airborne fungal (mold) spores.

Perennial rhinitis is caused by year-round exposure to indoor inhaled allergens (eg, dust mites, cockroaches, animal dander) or by strong reactivity to plant pollens in sequential seasons.

Allergic rhinitis and asthma frequently coexist; whether rhinitis and asthma result from the same allergic process (one-airway hypothesis) or rhinitis is a discrete asthma trigger is unclear.

The numerous nonallergic forms of perennial rhinitis include infectious, vasomotor, drug-induced (eg, aspirin- or NSAID-induced), and atrophic rhinitis (see Rhinitis).

Symptoms and Signs

Patients have itching (in the nose, eyes, or mouth), sneezing, rhinorrhea, and nasal and sinus obstruction. Sinus obstruction may cause frontal headaches; sinusitis is a frequent complication. Coughing and wheezing may also occur, especially if asthma is also present.

The most prominent feature of perennial rhinitis is chronic nasal obstruction, which, in children, can lead to chronic otitis media; symptoms vary in severity throughout the year. Itching is less prominent than in seasonal rhinitis.

Signs include edematous, bluish-red nasal turbinates, and, in some cases of seasonal allergic rhinitis, conjunctival injection and eyelid edema.

Diagnosis

  • Clinical evaluation

  • Occasionally skin testing, allergen-specific serum IgE tests, or both

Allergic rhinitis can almost always be diagnosed based on history alone. Diagnostic testing is not routinely needed unless patients do not improve when treated empirically; for such patients, skin tests (see Specific tests) are done to identify a reaction to pollens (seasonal) or to dust mite, cockroach, animal dander, mold, or other antigens (perennial), which can be used to guide additional treatment. Occasionally, skin test results are equivocal, or testing cannot be done (eg, because patients are taking drugs that interfere with results); then, an allergen-specific serum IgE test (see Allergic, Autoimmune, and Other Hypersensitivity Disorders:Specific tests) is done. Eosinophilia detected on nasal smear plus negative skin tests suggests aspirin sensitivity or nonallergic rhinitis with eosinophilia (NARES).

Diagnosis of nonallergic perennial rhinitis is usually also based on history. Lack of a clinical response to treatment for assumed allergic rhinitis and negative results on skin tests and/or an allergen-specific serum IgE test also suggest a nonallergic cause; disorders to consider include nasal tumors, enlarged adenoids, hypertrophic nasal turbinates, granulomatosis with polyangiitis (Wegener granulomatosis), and sarcoidosis.

Treatment

  • Antihistamines, decongestants, nasal corticosteroids, or a combination

  • For perennial rhinitis, removal or avoidance of allergens

  • For seasonal rhinitis, sometimes immunotherapy

  • For severe, refractory rhinitis, desensitization

Treatment of seasonal and perennial allergic rhinitis is generally the same, although attempts at environmental control (eg, eliminating dust mites and cockroaches—see Atopic and Allergic Disorders : Prevention) are recommended for perennial rhinitis.

The most effective first-line drug treatments are

Less effective alternatives include nasal mast cell stabilizers (eg, cromolyn) given bid to qid, the nasal H 1 blocker azelastine 2 puffs once/day, and nasal ipratropium 0.03% 2 puffs q 4 to 6 h, which relieves rhinorrhea. Nasal drugs are often preferred to oral drugs because less of the drug is absorbed systemically.

Inhaled Nasal Corticosteroids and Mast Cell Stabilizers

Drug

Dose per Spray

Initial Dose (Sprays per Nostril)

Sprays or Actuations per Canister

Inhaled nasal corticosteroids

Beclomethasone

42 mcg

6–12 yr: 1 spray bid

> 12 yr: 1 spray bid to qid

200

Budesonide

32 mcg

6 yr: 1 spray once/day

200

Flunisolide

29 mcg

6–14 yr: 1 spray tid or 2 sprays bid

Adults: 2 sprays bid

125

Fluticasone

50 mcg

4–12 yr: 1 spray once/day

> 12 yr: 2 sprays once/day

120

Mometasone

50 mcg

2–11 yr: 1 spray once/day

≥ 12 yr: 2 sprays once/day

120

Triamcinolone

55 mcg

> 6–12 yr: 1 spray once/day

> 12 yr: 2 sprays once/day

100

Mast cell stabilizers

Azelastine

137 mcg

5–11 yr: 1 spray bid

> 12 yr: 1–2 sprays bid

200

Cromolyn

5.2 mg

6 yr: 1 spray tid or qid

200

Olopatadine

665 mcg

6–11 yr: 1 spray bid

> 12 yr: 2 sprays bid

240

Intranasal saline, often forgotten, helps mobilize thick nasal secretions and hydrate nasal mucous membranes; various saline solution kits and irrigation devices (eg, squeeze bottles, bulb syringes) are available OTC, or patients can make their own solutions.

Desensitization immunotherapy may be more effective for seasonal than for perennial allergic rhinitis; it is indicated when

  • Symptoms are severe.

  • Allergen cannot be avoided.

  • Drug treatment is inadequate.

First attempts at desensitization should begin soon after the pollen season ends to prepare for the next season; adverse reactions increase when desensitization is started during the pollen season because the person’s allergic immunity is already maximally stimulated.

Montelukast, a leukotriene blocker, relieves allergic rhinitis symptoms, but its role relative to other treatments is uncertain. Omalizumab, an anti-IgE antibody, is under study for treatment of allergic rhinitis but will probably have a limited role because less expensive, effective alternatives are available.

Treatment of NARES is nasal corticosteroids. Treatment of aspirin sensitivity is avoidance of aspirin and nonselective NSAIDs (which can cross-react with aspirin), plus desensitization and leukotriene blockers as needed.

Key Points

  • Seasonal rhinitis is usually an allergic reaction to pollens.

  • Patients may have cough, wheezing, frontal headache, sinusitis, or, particularly in children with perennial rhinitis, otitis media.

  • Diagnosis is usually based on the history; skin tests and sometimes an allergen-specific serum IgE test are needed only when patients do not respond to empiric treatment.

  • Try nasal corticosteroids first because they are the most effective treatment and have few systemic effects.

Resources In This Article

Drugs Mentioned In This Article

  • Drug Name
    Select Trade
  • No US brand name
  • CUTIVATE, FLONASE
  • ASTELIN, OPTIVAR
  • SINGULAIR
  • AEROSPAN HFA
  • ATROVENT
  • CROLOM
  • PATANOL
  • XOLAIR
  • BECONASE
  • ELOCON, NASONEX
  • PULMICORT, RHINOCORT
  • KENALOG

* This is a professional Version *